
Jia-hai Lee
Examiner (ID: 893, Phone: (571)270-1691 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658 |
| Total Applications | 561 |
| Issued Applications | 242 |
| Pending Applications | 104 |
| Abandoned Applications | 235 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20005947
[patent_doc_number] => 20250144169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS
[patent_app_type] => utility
[patent_app_number] => 19/018888
[patent_app_country] => US
[patent_app_date] => 2025-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19018888
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/018888 | iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS | Jan 12, 2025 | Pending |
Array
(
[id] => 19658402
[patent_doc_number] => 20240425467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS
[patent_app_type] => utility
[patent_app_number] => 18/815249
[patent_app_country] => US
[patent_app_date] => 2024-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18815249
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/815249 | REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS | Aug 25, 2024 | Pending |
Array
(
[id] => 19658402
[patent_doc_number] => 20240425467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS
[patent_app_type] => utility
[patent_app_number] => 18/815249
[patent_app_country] => US
[patent_app_date] => 2024-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18815249
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/815249 | REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS | Aug 25, 2024 | Pending |
Array
(
[id] => 19570384
[patent_doc_number] => 20240374676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
[patent_app_type] => utility
[patent_app_number] => 18/783777
[patent_app_country] => US
[patent_app_date] => 2024-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783777
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/783777 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Jul 24, 2024 | Abandoned |
Array
(
[id] => 19570382
[patent_doc_number] => 20240374674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
[patent_app_type] => utility
[patent_app_number] => 18/783556
[patent_app_country] => US
[patent_app_date] => 2024-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783556
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/783556 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Jul 24, 2024 | Abandoned |
Array
(
[id] => 19554918
[patent_doc_number] => 20240366710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
[patent_app_type] => utility
[patent_app_number] => 18/783546
[patent_app_country] => US
[patent_app_date] => 2024-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783546
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/783546 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Jul 24, 2024 | Pending |
Array
(
[id] => 19570384
[patent_doc_number] => 20240374676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
[patent_app_type] => utility
[patent_app_number] => 18/783777
[patent_app_country] => US
[patent_app_date] => 2024-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783777
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/783777 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Jul 24, 2024 | Abandoned |
Array
(
[id] => 19570383
[patent_doc_number] => 20240374675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
[patent_app_type] => utility
[patent_app_number] => 18/783572
[patent_app_country] => US
[patent_app_date] => 2024-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783572
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/783572 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Jul 24, 2024 | Pending |
Array
(
[id] => 19541787
[patent_doc_number] => 20240358823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => CONJUGATED VACCINE CARRIER PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/434318
[patent_app_country] => US
[patent_app_date] => 2024-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18434318
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/434318 | CONJUGATED VACCINE CARRIER PROTEINS | Feb 5, 2024 | Pending |
Array
(
[id] => 19541787
[patent_doc_number] => 20240358823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => CONJUGATED VACCINE CARRIER PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/434318
[patent_app_country] => US
[patent_app_date] => 2024-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18434318
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/434318 | CONJUGATED VACCINE CARRIER PROTEINS | Feb 5, 2024 | Pending |
Array
(
[id] => 19316824
[patent_doc_number] => 20240238364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
[patent_app_type] => utility
[patent_app_number] => 18/431587
[patent_app_country] => US
[patent_app_date] => 2024-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18431587
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/431587 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Feb 1, 2024 | Pending |
Array
(
[id] => 19345217
[patent_doc_number] => 20240254180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => COMPOSITIONS OF PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 18/422878
[patent_app_country] => US
[patent_app_date] => 2024-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18422878
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/422878 | COMPOSITIONS OF PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Jan 24, 2024 | Pending |
Array
(
[id] => 20023248
[patent_doc_number] => 20250161470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => MITOCHONDRIAL INTERVENTION IN NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/413733
[patent_app_country] => US
[patent_app_date] => 2024-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18413733
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/413733 | MITOCHONDRIAL INTERVENTION IN NEUROLOGICAL DISORDERS | Jan 15, 2024 | Pending |
Array
(
[id] => 19543151
[patent_doc_number] => 20240360187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS
[patent_app_type] => utility
[patent_app_number] => 18/545392
[patent_app_country] => US
[patent_app_date] => 2023-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18545392
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/545392 | NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS | Dec 18, 2023 | Pending |
Array
(
[id] => 19496530
[patent_doc_number] => 20240335548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => MACROMOLECULES
[patent_app_type] => utility
[patent_app_number] => 18/507435
[patent_app_country] => US
[patent_app_date] => 2023-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507435
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/507435 | MACROMOLECULES | Nov 12, 2023 | Pending |
Array
(
[id] => 19216293
[patent_doc_number] => 20240180997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/386971
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18386971
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/386971 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | Nov 2, 2023 | Abandoned |
Array
(
[id] => 19216293
[patent_doc_number] => 20240180997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/386971
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18386971
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/386971 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | Nov 2, 2023 | Abandoned |
Array
(
[id] => 19201517
[patent_doc_number] => 20240173416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/501061
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501061
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/501061 | PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF | Nov 2, 2023 | Pending |
Array
(
[id] => 19201485
[patent_doc_number] => 20240173384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS
[patent_app_type] => utility
[patent_app_number] => 18/366130
[patent_app_country] => US
[patent_app_date] => 2023-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18366130
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/366130 | TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS | Aug 6, 2023 | Abandoned |
Array
(
[id] => 19127193
[patent_doc_number] => 20240132546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => CHARGE MODIFIED DESIGNED REPEAT DOMAINS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/362079
[patent_app_country] => US
[patent_app_date] => 2023-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18362079
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/362079 | CHARGE MODIFIED DESIGNED REPEAT DOMAINS AND THEIR USE | Jul 30, 2023 | Pending |